Anticonvulsants are medications that are used to treat epileptic seizures. These are frequently referred to as anti-epileptic or anti-seizure medications. Epilepsy is a chronic central nervous system (neurological) illness in which brain activity becomes aberrant, resulting in seizures or episodes of odd behavior, feelings, and, in rare cases, loss of consciousness. Bipolar disorder, borderline personality disorder, fibromyalgia, and neuropathic pain are all treated with anticonvulsant medications. Epilepsy can strike anyone at any time and in any age group. According to Epilepsy Society of the United Kingdom data from 2019, there are over 20 medications available for the treatment of epilepsy, including barbiturates, carboxamides, carbamates, and GABA analogs, as well as over 25 generics.
Global Anticonvulsants Market: Drivers
Anticonvulsants Market medicine approvals from the US Food and Drug Administration (FDA) are increasing, which is boosting the anticonvulsant market income. The FDA has authorized approximately 24 anticonvulsant medicines. The first medicine containing an active ingredient derived from marijuana was approved by the FDA in 2018 to treat rare, severe forms of epilepsy such as Lennox-Gastaut syndrome and Dravet syndrome.
Restraints in the Global Anticonvulsant Market
Anticonvulsants medications' adverse effects, such as mouth sores, blisters, or ulcers, excessive bleeding in wounds, stomach pain and tenderness, fever, and uncommon infections, are a major restraint on the market expansion.
Regional Analysis of the Global Anticonvulsants Market
Increasing demand for epilepsy treatment is likely to propel North America to the top of the anticonvulsants market during the forecast period.
The Anticonvulsants Market in the World: A Competitive Analysis
Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Novartis AG, Pfizer Inc., Valeant Pharmaceuticals International, Inc., Sanofi S.A., UCB Group, Shire Plc., GlaxoSmithKline Plc., Cephalon Inc., and AstraZeneca Plc. are some of the major players in the global anticonvulsants market.
Restraints in the Global Anticonvulsant Market
Anticonvulsants medications' adverse effects, such as mouth sores, blisters, or ulcers, excessive bleeding in wounds, stomach pain and tenderness, fever, and uncommon infections, are a major restraint on the market expansion.
Regional Analysis of the Global Anticonvulsants Market
Increasing demand for epilepsy treatment is likely to propel North America to the top of the anticonvulsants market during the forecast period.
The Anticonvulsants Market in the World: A Competitive Analysis
Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Novartis AG, Pfizer Inc., Valeant Pharmaceuticals International, Inc., Sanofi S.A., UCB Group, Shire Plc., GlaxoSmithKline Plc., Cephalon Inc., and AstraZeneca Plc. are some of the major players in the global anticonvulsants market.
0 Comments